Abstract
Congenital heart defects (CHDs) are the leading cause of death in infants under 1 year of age. Aberrations in the expression and function of cardiac transcription factors (TFs) are a major contributor to CHDs. Despite the numerous studies undertaken to functionally characterize these TFs, their exact role in different stages of cardiogenesis is still not fully elucidated. Here we focused on HEY2, a basic helix loop helix transcriptional repressor, and its potential role in human ventricular septal defects. Genetic analysis was performed based on sequencing of DNA and cDNA obtained from post-operational cardiac tissues and blood of 17 Lebanese patients with various CHDs. The screen covered the entire coding regions of the GATA4, NKX2.5, TBX5, TBX20 and HEY2 genes. Our results revealed two novel somatic mutations, namely p.Ala229Thr and p.161_190 del, affecting HEY2 in the diseased cardiac tissues of two patients with VSD. These results suggest a potential role of HEY2 in regulating ventricular septation in humans.
Similar content being viewed by others
Change history
13 May 2019
The original version of this article unfortunately contained a mistake in the author name. The first author name should be Manal Fardoun instead of Manal Fardon. The original article has been corrected.
References
Tennant PW, Pearce MS, Bythell M, Rankin J (2010) 20-year survival of children born with congenital anomalies: a population-based study. Lancet (London, England) 375(9715):649–656. https://doi.org/10.1016/s0140-6736(09)61922-x
Wren C, Irving CA, Griffiths JA, O’Sullivan JJ, Chaudhari MP, Haynes SR, Smith JH, Hamilton JR, Hasan A (2012) Mortality in infants with cardiovascular malformations. Eur J Pediatr 171(2):281–287. https://doi.org/10.1007/s00431-011-1525-3
Khoshnood B, Lelong N, Houyel L, Thieulin AC, Jouannic JM, Magnier S, Delezoide AL, Magny JF, Rambaud C, Bonnet D, Goffinet F (2012) Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study. Heart (British Cardiac Society) 98(22):1667–1673. https://doi.org/10.1136/heartjnl-2012-302543
Liu S, Joseph KS, Lisonkova S, Rouleau J, Van den Hof M, Sauve R, Kramer MS (2013) Association between maternal chronic conditions and congenital heart defects: a population-based cohort study. Circulation 128(6):583–589. https://doi.org/10.1161/circulationaha.112.001054
Oster ME, Lee KA, Honein MA, Riehle-Colarusso T, Shin M, Correa A (2013) Temporal trends in survival among infants with critical congenital heart defects. Pediatrics 131(5):e1502–e1508. https://doi.org/10.1542/peds.2012-3435
van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, Roos-Hesselink JW (2011) Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58(21):2241–2247. https://doi.org/10.1016/j.jacc.2011.08.025
Hoffman JI (1990) Congenital heart disease: incidence and inheritance. Pediatr Clin N Am 37(1):25–43
Benson DW (2002) The genetics of congenital heart disease: a point in the revolution. Cardiol Clin 20(3):385–394
Clark KL, Yutzey KE, Benson DW (2006) Transcription factors and congenital heart defects. Annu Rev Physiol 68:97–121. https://doi.org/10.1146/annurev.physiol.68.040104.113828
McCulley DJ, Black BL (2012) Transcription factor pathways and congenital heart disease. Curr Top Dev Biol 100:253–277. https://doi.org/10.1016/B978-0-12-387786-4.00008-7
Donovan J, Kordylewska A, Jan YN, Utset MF (2002) Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Curr Biol 12(18):1605–1610
Fischer A, Klamt B, Schumacher N, Glaeser C, Hansmann I, Fenge H, Gessler M (2004) Phenotypic variability in Hey2 -/- mice and absence of HEY2 mutations in patients with congenital heart defects or Alagille syndrome. Mamm Genome 15(9):711–716. https://doi.org/10.1007/s00335-004-2389-x
Anderson DJ, Kaplan DI, Bell KM, Koutsis K, Haynes JM, Mills RJ, Phelan DG, Qian EL, Leitoguinho AR, Arasaratnam D, Labonne T, Ng ES, Davis RP, Casini S, Passier R, Hudson JE, Porrello ER, Costa MW, Rafii A, Curl CL, Delbridge LM, Harvey RP, Oshlack A, Cheung MM, Mummery CL, Petrou S, Elefanty AG, Stanley EG, Elliott DA (2018) NKX2-5 regulates human cardiomyogenesis via a HEY2 dependent transcriptional network. Nat Commun 9(1):1373. https://doi.org/10.1038/s41467-018-03714-x
Fahed AC, Gelb BD, Seidman JG, Seidman CE (2013) Genetics of congenital heart disease: the glass half empty. Circ Res 112(4):707–720. https://doi.org/10.1161/circresaha.112.300853
Fischer A, Gessler M (2003) Hey genes in cardiovascular development. Trends Cardiovasc Med 13(6):221–226
(2018) https://www.ncbi.nlm.nih.gov/gene/23493. Accessed 2 Feb 2018
Koibuchi N, Chin MT (2007) CHF1/Hey2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression. Circ Res 100(6):850–855. https://doi.org/10.1161/01.RES.0000261693.13269.bf
Miao L, Li J, Li J, Tian X, Lu Y, Hu S, Shieh D, Kanai R, Zhou BY, Zhou B, Liu J, Firulli AB, Martin JF, Singer H, Zhou B, Xin H, Wu M (2018) Notch signaling regulates Hey2 expression in a spatiotemporal dependent manner during cardiac morphogenesis and trabecular specification. Sci Rep 8(1):2678. https://doi.org/10.1038/s41598-018-20917-w
Yehya A, Souki R, Bitar F, Nemer G (2006) Differential duplication of an intronic region in the NFATC1 gene in patients with congenital heart disease. Genome 49(9):1092–1098. https://doi.org/10.1139/g06-072
Yang YQ, Wang J, Liu XY, Chen XZ, Zhang W, Wang XZ, Liu X, Fang WY (2012) Novel GATA4 mutations in patients with congenital ventricular septal defects. Med Sci Monit 18(6):Cr344–Cr350
Simpson L, Emeson RB (1996) RNA editing. Annu Rev Neurosci 19:27–52. https://doi.org/10.1146/annurev.ne.19.030196.000331
van Leeuwen FW, Burbach JP, Hol EM (1998) Mutations in RNA: a first example of molecular misreading in Alzheimer’s disease. Trends Neurosci 21(8):331–335
Laxminarayana D, Kammer GM (2000) mRNA mutations of type I protein kinase A regulatory subunit alpha in T lymphocytes of a subject with systemic lupus erythematosus. Int Immunol 12(11):1521–1529
Reamon-Buettner SM, Borlak J (2005) HEY2 Mutations in Malformed Hearts. Hum Mutat 27(1):118
Acknowledgements
We thank all patients for their participation in the study. Special thanks to Mrs. Inaam El-Rassy in the Molecular Core facility for Sanger sequencing. This work was supported by an MPP/URB Grant from the American University of Beirut.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original version of this article was revised: The typo in the first-author's second name is corrected from "Fardon" to "Fardoun".
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fardoun, M., Dehaini, H., Kamar, A. et al. A Novel Somatic Variant in HEY2 Unveils an Alternative Splicing Isoform Linked to Ventricular Septal Defect. Pediatr Cardiol 40, 1084–1091 (2019). https://doi.org/10.1007/s00246-019-02099-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-019-02099-y